Skip to main content
OpenTrials

Clinical trial condition

Metastatic NSCLC

Explore clinical trials studying Metastatic NSCLC. Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Metastatic NSCLC trial results

Recruiting

De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction

NCT05255302

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Aix-en-Provence - CH Aix-en-Provence, France
  • Amiens - Clinique de l'Europe Amiens, France
  • Angers - CHU Angers, France
  • Avignon - CH Avignon, France
View all 44 locations
View Trial Details
Recruiting

Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study

NCT04170634

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +14 more
Locations
  • Service de rhumatologie, CHU d'Angers Angers, France
  • Ch Annecy Genevois Annecy, France
  • Service de radiothérapie, Institut Jean-Perrin Clermont-Ferrand, France
  • Service de rhumatologie, CH Annemasse Contamine-sur-Arve, France
View Trial Details
Completed

A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)

NCT06159790

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Sandoz Investigational Site Fountain Valley, California, United States
  • Sandoz Investigational Site Banja Luka, Bosnia and Herzegovina
  • Sandoz Investigational Site Sarajevo, Bosnia and Herzegovina
  • Sandoz Investigational Site Zenica, Bosnia and Herzegovina
View all 62 locations
View Trial Details
Active, Not Recruiting

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

NCT03589339

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +47 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 13 locations
View Trial Details

Related conditions